Here's How Gene-Editing Treatment Changed the Lives of Hereditary Disorder Patients Across 3 Countries
Researchers unveil NTLA-2002, a groundbreaking CRISPR gene therapy, providing promising results in treating hereditary angioedema with potential for lifelong relief and broader applications in genetic disorders.
Source: techtimes.com
